Skip to main content
Clinical Trials/NCT00744458
NCT00744458
Completed
N/A

A Prospective Randomised Trial Comparing Three Interventions to Improve Treatment Adherence Among Patients With Arterial Hypertension or Diabetes in Rural Cameroon (TAHADIRA-trial 1)

Cooperation Afrique1 site in 1 country223 target enrollmentAugust 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diabetes
Sponsor
Cooperation Afrique
Enrollment
223
Locations
1
Primary Endpoint
Percentage of patients with regular follow-up one year after the treatment was started
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to determine the efficacy of three different interventions to improve treatment adherence among patients with arterial hypertension or diabetes in rural Cameroon.

Detailed Description

Non communicable chronic diseases such as arterial hypertension (AH) and diabetes (DM) are a great burden for public health in Cameroon. However, outside the main cities access to appropriate diagnosis and treatment of these health-conditions is still very poor. The Swiss NGO "Fondation Coopération Afrique" started in 2007 a program to integrate chronic disease management with focus on AH and DM into the primary health care system of peripheral non-physician health facilities in a rural area of Central Cameroon. A first evaluation after one year revealed very low treatment adherence among the newly diagnosed patients as the main challenge. In order to improve patient's adherence we expose them randomly to one of three interventions: The first intervention consists in a written agreement on long-lasting therapy (treatment contract). Patients get information about the importance of a regular long term treatment and personal engagement to follow treatment and clinical controls regularly. The second intervention introduces in addition to the treatment contract a reminder system. In case of follow-up failure a community worker traces the patient to recall the visit at the health centre. The third intervention consists of the treatment contract combined with a financial incentive in form of one month free treatment after four months of regular follow-up. We allocated randomly one of the three interventions to each health center.

Registry
clinicaltrials.gov
Start Date
August 2008
End Date
February 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Cooperation Afrique

Eligibility Criteria

Inclusion Criteria

  • Patients with newly diagnosed arterial hypertension or non insulin dependent diabetes type 2 which require treatment and can be treated in the health centre
  • Informed consent by the patient

Exclusion Criteria

  • Patient already under treatment
  • Patients who need to be referred to a hospital
  • No informed consent by the patient

Outcomes

Primary Outcomes

Percentage of patients with regular follow-up one year after the treatment was started

Time Frame: One patient year

Secondary Outcomes

  • Percentage of missed control-visits(One patient year)
  • Treatment response of diabetic patients (fasting blood glucose)(One patient year)
  • Treatment response of patients with arterial hypertension (blood pressure)(One patient year)

Study Sites (1)

Loading locations...

Similar Trials